Blueprint Neurotherapeutics Network (BPN) for Small Molecules Q&A Webinar

The Blueprint Neurotherapeutics Network for Small Molecule (BPN-Small Molecule), which provides non-dilutive support for small molecule drug discovery and development, from hit-to-lead chemistry through phase I clinical testing, will hold a Q&A Webinar for potential applicants on Wednesday, April 24, 2024, 3:00 PM EST.

Program Director Dr. Charles Cywin will provide an overview of the program and answer questions about the application process.

• PAR-20-111 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
• PAR-20-122 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

All investigators who are interested in learning about the BPN-Small Molecule program are encouraged to register and participate.  You can also submit questions before the meeting to Rakonda Medley. 

Register in advance for this webinar!